How should I adjust the lithium dose in an adult with normal renal function and no signs of toxicity who has a serum lithium concentration of 1.59 mEq/L?

Immediate Lithium Dose Adjustment Required

You must hold the next lithium dose immediately and reduce the maintenance dose, as a serum level of 1.59 mEq/L exceeds the therapeutic range and approaches toxicity. 1

Understanding the Current Situation

Your patient's lithium level of 1.59 mEq/L is significantly elevated:

• Therapeutic range for maintenance: 0.6-0.8 mEq/L (preferred) or up to 1.2 mEq/L maximum 1, 2
• Mild toxicity threshold: 1.5-2.5 mEq/L 3
• Your patient's level (1.59 mEq/L) falls into the mild toxicity range 3

The FDA label explicitly states that patients "abnormally sensitive to lithium may exhibit toxic signs at serum levels of 1 to 1.5 mEq/L," and elderly patients particularly "may exhibit signs of toxicity at serum levels ordinarily tolerated by other patients." 1

Immediate Management Steps

1. Hold Current Dose

Skip the next scheduled lithium dose entirely. 4 This allows the elevated level to decline before resuming therapy.

2. Assess for Toxicity Signs

Evaluate immediately for symptoms of lithium toxicity, including:

• Neurological: tremor (coarse, not fine), confusion, ataxia, slurred speech, muscle weakness 3
• Gastrointestinal: nausea, vomiting, diarrhea 3
• Cardiovascular: arrhythmias 3
• Renal: polyuria, polydipsia 5

3. Check Renal Function

Measure serum creatinine and calculate GFR immediately. 4 Lithium clearance is almost exclusively renal, and any decline in kidney function dramatically increases toxicity risk. 6, 5

4. Review Interacting Medications

Temporarily discontinue or review these medications if present 4:

• ACE inhibitors or ARBs (reduce lithium clearance by 30-40%) 7
• NSAIDs (reduce lithium clearance) 7
• Diuretics, especially thiazides (increase lithium reabsorption) 7
• These should have been stopped during any acute illness per KDIGO guidelines 4

Dose Reduction Strategy

For Patients with Normal Renal Function (GFR ≥60 mL/min/1.73m²)

Reduce the total daily dose by 25-33% when resuming therapy. 8, 9 For example:

• If currently on 900 mg/day → reduce to 600-675 mg/day
• If currently on 1200 mg/day → reduce to 800-900 mg/day

Recheck lithium level in 5-7 days (approximately 5 half-lives to reach new steady state, given lithium's 18-36 hour half-life). 6

For Patients with Renal Impairment (GFR 30-59 mL/min/1.73m²)

Reduce the total daily dose by 50% and consider extending dosing intervals. 4, 5

Target the lower therapeutic range of 0.4-0.6 mEq/L in patients with any degree of renal impairment. 8, 5

Recheck lithium level in 3-5 days due to prolonged elimination. 5

For Patients with GFR <30 mL/min/1.73m²

Strongly consider discontinuing lithium and consulting nephrology. 5 The KDIGO guidelines recommend temporary discontinuation of lithium in patients with serious intercurrent illness that increases AKI risk. 4

If continuation is deemed essential for psychiatric stability, reduce dose by at least 50-75% and monitor levels every 3-5 days. 5

Target Therapeutic Range

Aim for 0.6-0.8 mEq/L for most adult patients in maintenance therapy. 2, 8 This range provides optimal efficacy while minimizing adverse effects. 2

For patients ≥50 years old, target 0.5-0.6 mEq/L due to increased sensitivity to neurotoxicity. 8

For patients with comorbid conditions (diabetes insipidus, thyroid dysfunction, or taking ACE inhibitors/diuretics/NSAIDs), also target the lower range of 0.5-0.6 mEq/L. 8

Ongoing Monitoring After Adjustment

• Recheck lithium level 5-7 days after dose change (at steady state) 1, 6
• Draw levels 12 hours post-dose for standard formulations or 24 hours post-dose for once-daily dosing 1, 6
• Once stable, monitor every 3 months if age <65 years, or every 8-10 weeks if elderly 5, 10
• Monitor renal function (creatinine, GFR) every 3 months during lithium therapy 4, 5

Critical Pitfalls to Avoid

Do not simply continue the current dose hoping the level will spontaneously decrease—this risks progression to moderate-severe toxicity (>2.5 mEq/L). 3

Do not target levels >1.0 mEq/L in maintenance therapy, as this increases toxicity risk without additional efficacy benefit in most patients. 2, 8

Do not overlook medication interactions—ACE inhibitors, ARBs, NSAIDs, and diuretics can increase lithium levels by 30-50%. 7

Do not use higher target ranges in elderly patients—they exhibit toxicity at lower levels than younger adults. 1, 8